Relapsing-remitting multiple sclerosis

There are 72 papers on relapsing-remitting multiple sclerosis in aging research: 30 trials and 30 observational studies in people, 1 in animals, 1 in cells, 8 reviews. The newest story, Nov 2, 2026: “Gray matter volume fell in relapsing-remitting multiple sclerosis”.

Disease

72 papers study it10 more mention it8 findings

4 new papers in 30 daysSee all 82 papers on relapsing-remitting multiple sclerosis

“MS showed greater GM-VL in the right SFC, caudal-middle frontal cortex, caudate, and left frontal pole (all Z > 2.08, p < 0.019).”
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageingNeuroImage2026doi:10.1016/j.neuroimage.2026.122118
  • Human trial30
  • Humans30
  • Animals1
  • Cells1

Effects

4

Telomere length

downin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is linked with lower telomere length in humans (relapsing-remitting multiple sclerosis) (AUC = 0.698 (95% CI: 0.60–0.79)).

    Humansrelapsing-remitting multiple sclerosis

More on Telomere length

Gray matter volume loss

upin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is linked with higher gray matter volume loss in RRMS compared with healthy controls >20 years older (all Z > 2.08, p < 0.019).

    Humansin RRMS compared with healthy controls >20 years older

    Gray matter volume fell in relapsing-remitting multiple sclerosis

    NeuroImage

More on Gray matter volume loss

STAT3

upin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is linked with higher STAT3 in CD4+CD25+FoxP3+ and CD8+CD25+FoxP3+ Tregs.

    Humansin CD4+CD25+FoxP3+ and CD8+CD25+FoxP3+ Tregsbloodfemales

More on STAT3

IL-6R

upin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is linked with higher IL-6R in CD8+CD122+ Tregs.

    Humansin CD8+CD122+ Tregsbloodfemales

More on IL-6R

Associations

4

Telomere length

downin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is associated with telomere length in patients with RRMS vs healthy controls.

    Humansin patients with RRMS vs healthy controlsleukocyte

More on Telomere length

ALPS index

downin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is associated with ALPS index in humans (Compared with non-MS controls).

    HumansCompared with non-MS controlsbrain

More on ALPS index

Anemia

upin humans1

1 study
  1. Relapsing-remitting multiple sclerosis is associated with anemia in humans (relapsing-remitting multiple sclerosis).

    Humansrelapsing-remitting multiple sclerosisn = 76

More on Anemia

Malnutrition

upin humans1+67%

1 study
  1. Relapsing-remitting multiple sclerosis is associated with malnutrition in humans (relapsing-remitting multiple sclerosis) (67.1%).

    Humansrelapsing-remitting multiple sclerosisn = 76

More on Malnutrition

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 1Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 3Jul 2026: 3Aug 2026: 1Sep 2026: 1Oct 2026: 3Nov 2026: 319 papers in 12 months
NeuroImage

Gray matter volume fell in relapsing-remitting multiple sclerosis

Gray matter loss in 386 people with relapsing-remitting multiple sclerosis was comparable to that in healthy people 20 years older.Gray matter loss in 386 people with relapsing-remitting multiple sclerosis was comparable to that in healthy people 20 years older.

See all 82 papers on relapsing-remitting multiple sclerosis